Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.
Related Posts
Stock Markets Down as Recession Fears Rise
Investors fear that tit-for-tat tariffs could raise prices, slow growth and sow uncertainty among businesses.
Bacteria Found in Tom’s of Maine Toothpaste, Inspectors Say
The U.S. Food and Drug Administration issued a warning letter, but not a recall, after microorganisms were found in water samples and finished toothpaste products.
While N.B.A. Plays in Abu Dhabi, Critics Cry Foul
The league has held preseason games in the United Arab Emirates for three years. It says its impact has been positive, but others say it’s […]